Insights of SEDRIC, the Surveillance and Epidemiology of Drug-Resistant Infections Consortium
Feasey N., Ahmad R., Ashley E., Atun R., Baker KS., Chiari F., van Doorn HR., Holmes A., Jinks T., Jermy A., Joshi J., Kanj SS., King M., Limmathurotsakul D., Midega J., Mpundu M., Nunn J., Okeke IN., Reid S., Sievert D., Turner P., Walia K., Peacock SJ.
The increasing threat from infection with drug-resistant pathogens is among the most serious public health challenges of our time. Formed by Wellcome in 2018, the Surveillance and Epidemiology of Drug-Resistant Infections Consortium (SEDRIC) is an international think tank whose aim is to inform policy and change the way countries track, share, and analyse data relating to drug-resistant infections, by defining knowledge gaps and identifying barriers to the delivery of global surveillance. SEDRIC delivers its aims through discussions and analyses by world-leading scientists that result in recommendations and advocacy to Wellcome and others. As a result, SEDRIC has made key contributions in furthering global and national actions. Here, we look back at the work of the consortium between 2018-2024, highlighting notable successes. We provide specific examples where technical analyses and recommendations have helped to inform policy and funding priorities that will have real-world impact on the surveillance and epidemiology of infections with drug-resistant pathogens.